Search Results - "Taskar, Kunal"

Physiologically‐Based Pharmacokinetic Modeling to Support Pediatric Clinical Development: An IQ Working Group Perspective on the Current Status and Challenges.

Authors: Yates, James W. T. Zientek, Michael Taskar, Kunal S. et al.

Source: CPT: Pharmacometrics & Systems Pharmacology. Jan2026, Vol. 15 Issue 1, p1-19. 19p.

Drug transporters in drug disposition – the year 2022 in review.

Authors: Chothe, Paresh P. Mitra, Pallabi Nakakariya, Masanori et al.

Source: Drug Metabolism Reviews. Nov2023, Vol. 55 Issue 4, p343-370. 28p.

No dose adjustment of metformin or substrates of organic cation transporters (OCT)1 and OCT2 and multidrug and toxin extrusion protein (MATE)1/2K with fostemsavir coadministration based on modeling approaches.

Authors: Nguyen, Dung Miao, Xiusheng Taskar, Kunal et al.

Source: Pharmacology Research & Perspectives. Aug2024, Vol. 12 Issue 4, p1-10. 10p.

Physiologically‐Based Pharmacokinetic Modeling of the PARP Inhibitor Niraparib.

Authors: Lewis, Gareth J. Jewell, Roxanne C. Krishnatry, Anu Shilpa et al.

Source: CPT: Pharmacometrics & Systems Pharmacology. Jan2026, Vol. 15 Issue 1, p1-12. 12p.

Development of a physiologically based pharmacokinetic model of fostemsavir and its pivotal application to support dosing in pregnancy.

Authors: Salem, Farzaneh Nguyen, Dung Bush, Mark et al.

Source: CPT: Pharmacometrics & Systems Pharmacology. Nov2024, Vol. 13 Issue 11, p1881-1892. 12p.

Physiologically‐based pharmacokinetic modeling of prominent oral contraceptive agents and applications in drug–drug interactions.

Authors: Lewis, Gareth J. Ahire, Deepak Taskar, Kunal S.

Source: CPT: Pharmacometrics & Systems Pharmacology. Apr2024, Vol. 13 Issue 4, p563-575. 13p.

Physiologically based pharmacokinetic modeling for development and applications of a virtual celiac disease population using felodipine as a model drug.

Authors: Salem, Farzaneh Nimavardi, Ali Mudunuru, Jennypher et al.

Source: CPT: Pharmacometrics & Systems Pharmacology. Jun2023, Vol. 12 Issue 6, p808-820. 13p.

Matrix Approach Assessment of Cabotegravir Drug–Drug Interactions with OAT1/OAT3 Substrates and UGT1A1/UGT1A9 Inhibitors Using Physiologically-Based Pharmacokinetic Modeling.

Authors: Tracey, Helen Bate, Simon T. Ford, Susan et al.

Source: Pharmaceutics. Apr2025, Vol. 17 Issue 4, p531. 20p.

Physiologically‐based pharmacokinetic model‐based translation of OATP1B‐mediated drug–drug interactions from coproporphyrin I to probe drugs.

Authors: Mochizuki, Tatsuki Aoki, Yasunori Yoshikado, Takashi et al.

Source: CTS: Clinical & Translational Science. Jun2022, Vol. 15 Issue 6, p1519-1531. 13p.

Robust physiologically based pharmacokinetic model of rifampicin for predicting drug–drug interactions via P‐glycoprotein induction and inhibition in the intestine, liver, and kidney.

Authors: Asaumi, Ryuta Nunoya, Ken‐ichi Yamaura, Yoshiyuki et al.

Source: CPT: Pharmacometrics & Systems Pharmacology. Jul2022, Vol. 11 Issue 7, p919-933. 15p.

Contemporary Issues in Pregnancy (and Offspring) in the Current HIV Era.

Authors: Eckard AR Kirk SE Hagood NL

Source: Current HIV/AIDS reports [Curr HIV/AIDS Rep] 2019 Dec; Vol. 16 (6), pp. 492-500.

Publication Type: Journal Article; Review

Journal Info: Publisher: Current Science Country of Publication: United States NLM ID: 101235661 Publication Model: Print Cited Medium: Internet ISSN: 1548-3576 (Electronic) Linking ISSN: 15483568 NLM ISO Abbreviation: Curr HIV/AIDS Rep Subsets: MEDLINE